4 completed, 4 suspended, 2 unknown, 1 terminated. 10 Phase 2, 7 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 4, Suspended 3, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 1 | 7 | Completed 4, Suspended 2, Withdrawn 1 |
| Phase 3 | 2 | Suspended 1, Unknown 1 |
Follow Hokkaido Gastrointestinal Cancer Study Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer Campto, Topotesin, TS-1, L-Plat - Metastatic Colorectal Cancer | Phase 3 | Suspended | Hokkaido Gastrointestinal Cancer Study Group | 200 | 2006-04-01 | 2007-11-01 |
| Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer. Taxotere, TS-1 - Gastric Cancer | Phase 1 / Phase 2 | Suspended | Hokkaido Gastrointestinal Cancer Study Group | 50 | 2005-04-01 | 2010-05-26 |
| Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer UFT, USEL/Leucovorin, Krestin - Colorectal Cancer | Phase 3 | Unknown | Hokkaido Gastrointestinal Cancer Study Group | 340 | 2005-04-01 | 2010-05-26 |
| Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer Oxaliplatin, l-Leucovorin, 5-Fluorouracil - Colorectal Cancer | Phase 2 | Terminated | Hokkaido Gastrointestinal Cancer Study Group | 30 | 2005-01-01 | 2006-04-21 |
| Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Gemcitabine, S-1 - Pancreatic Cancer | Phase 1 / Phase 2 | Suspended | Hokkaido Gastrointestinal Cancer Study Group | 40 | 2004-12-01 | 2007-11-01 |
| Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC. Taxol, Campt, Topotesin - Gastric Cancer | Phase 1 / Phase 2 | Withdrawn | Hokkaido Gastrointestinal Cancer Study Group | 40 | 2004-04-01 | 2009-02-17 |
| Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer Campto, Topotesin, TS-1 - Colorectal Cancer | Phase 2 | Unknown | Hokkaido Gastrointestinal Cancer Study Group | 40 | 2004-01-01 | 2007-11-01 |
| Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer irinotecan, S-1 - Gastric Cancer | Phase 2 | Suspended | Hokkaido Gastrointestinal Cancer Study Group | 40 | 2004-01-01 | 2006-02-02 |
| Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. Taxotere, 5-Fluorouracil, Briplatin - Esophageal Cancer | Phase 1 / Phase 2 | Completed | Hokkaido Gastrointestinal Cancer Study Group | 30 | 2003-12-01 | 2010-05-26 |
| Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. Taxotere, 5-FU, Briplatin - Esophageal Cancer | Phase 1 / Phase 2 | Completed | Hokkaido Gastrointestinal Cancer Study Group | 30 | 2003-10-01 | 2010-05-26 |
| Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer irinotecan, S-1 - Gastric Cancer | Phase 1 / Phase 2 | Completed | Hokkaido Gastrointestinal Cancer Study Group | 24 | 2000-05-01 | 2006-04-21 |
| Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer irinotecan, leucovorin, fluorouracil - Colorectal Cancer | Phase 1 / Phase 2 | Completed | Hokkaido Gastrointestinal Cancer Study Group | 23 | 2000-04-01 | 2005-09-21 |
Colorectal Neoplasms (5) · Stomach Neoplasms (4) · Esophageal Neoplasms (2) · Pancreatic Neoplasms (1)
Irinotecan (6) · S 1 (combination) (6) · Fluorouracil (5) · Leucovorin (4) · Docetaxel (3) · titanium silicide (3) · Cisplatin (2) · Oxaliplatin (2) · DCM-Dex-CDDP (1) · Gemcitabine (1) · Paclitaxel (1) · Tegafur (1) · polysaccharide-K (1)
Japan (11)
Masahiro Asaka, MD, PhD (9) · Yoshito Komatsu, MD, PhD (2) · Yoshito Komatsu, MD.PhD (1)